Encounter decision aid vs. clinical decision support or usual care to support patient-centered treatment decisions in osteoporosis: The Osteoporosis Choice randomized trial II

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  LeBlanc, Annie ^a   Wang, Amy T ^b   Wyatt, Kirk ^a   Branda, Megan E ^a   Shah, Nilay D ^a   Van Houten, Holly ^a   Pencille, Laurie ^a   Wermers, Robert ^a   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL DECISION MAKING; CONFLICT; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; FEMALE; FRAGILITY FRACTURE; FRAX CALCULATOR; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE ASSESSMENT; OSTEOPENIA; OSTEOPOROSIS; OSTEOPOROSIS CHOICE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SHARED DECISION MAKING; TREATMENT PLANNING; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL TRIAL; MEDICATION COMPLIANCE; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PROCEDURES;

AGED; DECISION SUPPORT SYSTEMS, CLINICAL; DECISION SUPPORT TECHNIQUES; DIPHOSPHONATES; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION;

EID: 84930225511     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128063     Document Type: Article

References (19)

1. Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Suttorp MJ, et al. (2012). Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: Update of a 2007 Report. Rockville (MD).
2. National Osteoporosis Foundation (2013) Clinician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation.
3. Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int doi:101007/s00198-006-0322-8 18: 1023-1031. PMID: 17308956
4. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, et al. (2007) Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int doi:101007/s00198-006-0294-8 18: 711-719. PMID: 17245547
5. Montori VM, Shah ND, Pencille LJ, Branda ME, Van Houten HK, Swiglo BA, et al. (2011) Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med 124: 549-556. doi: 10.1016/j.amjmed.2011.01.013 PMID: 21605732
6. Scoville EA, Ponce de Leon Lovaton P, Shah ND, Pencille LJ, Montori VM (2011) Why do women reject bisphosphonates for osteoporosis? A videographic study. PLoS ONE 6: e18468. doi: 10.1371/journal.pone.0018468 PMID: 21533288
7. McCloskey E, Kanis JA (2012) FRAX updates 2012. Curr Opin Rheumatol 24: 554-560. doi: 10.1097/BOR.0b013e328356d2f5 PMID: 22820516
8. Kanis JA, World Health Organization Scientific G (2007) Assessment of Osteoporosis at the Primary Health Care Level. Technical Report.
9. Pencille LJ, Campbell ME, Van Houten HK, Shah ND, Mullan RJ, Swiglo BA, et al. (2009) Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice. Trials 10: 113. doi: 10.1186/1745-6215-10-113 PMID: 20003299
10. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Welch V, et al. (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane database of systematic reviews: CD001155.
11. O'Connor AM (1995) Validation of a decisional conflict scale. Med Decis Making 15: 25-30. PMID: 7898294
12. Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. The Ann Pharmacother 40: 1280-1288. PMID: 16868217
13. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Hudson TJ, et al. (2008) An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 46: 1125-1133. doi: 10.1097/MLR.0b013e31817924d2 PMID: 18953222
14. Elwyn G, Edwards A, Wensing M, Hood K, Atwell C, Grol R. (2003) Shared decision making: developing the OPTION scale for measuring patient involvement. Qual Saf Health Care 12: 93-99. PMID: 12679504
15. Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Medi 33: 337-343.
16. Montori VM, Guyatt GH (2001) Intention-to-treat principle. CMAJ 165: 1339-1341. PMID: 11760981
17. Cranney A, O'Connor AM, Jacobsen MJ, Tugwell P, Adachi JD, et al. (2002) Development and pilot testing of a decision aid for postmenopausal women with osteoporosis. Patient Educ Couns doi:101016/S0738-3991(01)00218-X 47: 245-255. PMID: 12088603
18. Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Gordon H, et al. (2009) The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 169: 1560-1568. doi: 10.1001/archinternmed.2009.293 PMID: 19786674
19. Wyatt KD, Branda ME, Anderson RT, Pencille LJ, Montori VM, et al. (2014) Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters. Implementation science 9: 26. doi: 10.1186/1748-5908-9-26 PMID: 24559190